{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T03:21:21Z","timestamp":1781580081329,"version":"3.54.5"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,14]]},"DOI":"10.7759\/cureus.36126","type":"journal-article","created":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T11:35:51Z","timestamp":1678793751000},"source":"Crossref","is-referenced-by-count":4,"title":["Primary Sclerosing Cholangitis-Autoimmune Hepatitis Overlap Syndrome: Significant Barriers in Liver Disease Diagnosis and Treatment Experienced by the Latino Community"],"prefix":"10.7759","author":[{"given":"Daniel A","family":"Guifarro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"De Oliveira-Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Beas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel  J","family":"Yibrin-Wakim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleazar  E","family":"Montalvan-Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.09.002","article-title":"Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue","volume":"54","author":"Boberg KM","year":"2011","unstructured":"Boberg KM, Chapman RW, Hirschfield GM, Lohse AW, Manns MP, Schrumpf E. Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue. J Hepatol. 2011, 54:374-85. 10.1016\/j.jhep.2010.09.002","journal-title":"J Hepatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.14.3368","article-title":"Overlap syndromes among autoimmune liver diseases","volume":"14","author":"Rust C","year":"2008","unstructured":"Rust C, Beuers U. Overlap syndromes among autoimmune liver diseases. World J Gastroenterol. 2008, 14:3368-73. 10.3748\/wjg.14.3368","journal-title":"World J Gastroenterol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v8.i18.4075","article-title":"Primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome associated with inflammatory bowel disease: a case report and systematic review","volume":"8","author":"Ballotin VR","year":"2020","unstructured":"Ballotin VR, Bigarella LG, Riva F, Onzi G, Balbinot RA, Balbinot SS, Soldera J. Primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome associated with inflammatory bowel disease: a case report and systematic review. World J Clin Cases. 2020, 8:4075-93. 10.12998\/wjcc.v8.i18.4075","journal-title":"World J Clin Cases"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.08.002","article-title":"Long-term outcome in PSC\/AIH \"overlap syndrome\": does immunosuppression also treat the PSC component?","volume":"61","author":"Zenouzi R","year":"2014","unstructured":"Zenouzi R, Lohse AW. Long-term outcome in PSC\/AIH \"overlap syndrome\": does immunosuppression also treat the PSC component?. J Hepatol. 2014, 61:1189-91. 10.1016\/j.jhep.2014.08.002","journal-title":"J Hepatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.21037\/tgh-20-266","article-title":"Primary sclerosing cholangitis","volume":"6","author":"Rabiee A","year":"2021","unstructured":"Rabiee A, Silveira MG. Primary sclerosing cholangitis. Transl Gastroenterol Hepatol. 2021, 6:29. 10.21037\/tgh-20-266","journal-title":"Transl Gastroenterol Hepatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2017.12.017","article-title":"Increased waitlist mortality and lower rate for liver transplantation in Hispanic patients with primary biliary cholangitis","volume":"16","author":"Cholankeril G","year":"2018","unstructured":"Cholankeril G, Gonzalez HC, Satapathy SK, et al.. Increased waitlist mortality and lower rate for liver transplantation in Hispanic patients with primary biliary cholangitis. Clin Gastroenterol Hepatol. 2018, 16:965-973.e2. 10.1016\/j.cgh.2017.12.017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.7298","article-title":"Small duct primary sclerosing cholangitis: an underdiagnosed cause of chronic liver disease and cirrhosis","volume":"12","author":"Deliwala S","year":"2020","unstructured":"Deliwala S, Sundus S, Haykal T, Elbedawi MM, Bachuwa G. Small duct primary sclerosing cholangitis: an underdiagnosed cause of chronic liver disease and cirrhosis. Cureus. 2020, 12:e7298. 10.7759\/cureus.7298","journal-title":"Cureus"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0244744","article-title":"Liver transplant waitlist removal, transplantation rates and post-transplant survival in Hispanics","volume":"15","author":"Thuluvath PJ","year":"2020","unstructured":"Thuluvath PJ, Amjad W, Zhang T. Liver transplant waitlist removal, transplantation rates and post-transplant survival in Hispanics. PLoS One. 2020, 15:e0244744. 10.1371\/journal.pone.0244744","journal-title":"PLoS One"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/lt.25996","article-title":"Racial, gender, and socioeconomic disparities in liver transplantation","volume":"27","author":"Nephew LD","year":"2021","unstructured":"Nephew LD, Serper M. Racial, gender, and socioeconomic disparities in liver transplantation. Liver Transpl. 2021, 27:900-12. 10.1002\/lt.25996","journal-title":"Liver Transpl"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.14740\/gr1514","article-title":"Upper gastrointestinal cancer: delays in diagnosis and treatment caused by barriers to healthcare in the Latino community","volume":"15","author":"Montalvan-Sanchez EE","year":"2022","unstructured":"Montalvan-Sanchez EE, Beas R, Norwood DA, Alkashash AM, Rodriguez Murillo AA, Calderon G. Upper gastrointestinal cancer: delays in diagnosis and treatment caused by barriers to healthcare in the Latino community. Gastroenterology Res. 2022, 15:142-7. 10.14740\/gr1514","journal-title":"Gastroenterology Res"},{"key":"ref11","article-title":"Survival of gastric cancer in western Honduras pilot study: 2002-2012","volume":"85(1)","author":"Montalvan EE","year":"2017","unstructured":"Montalvan EE, Montalvan DM, Urrutia SA, et al.. Survival of gastric cancer in western Honduras pilot study: 2002-2012. Rev Med Hondur. 2017, 85(1):6-10.","journal-title":"Rev Med Hondur"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2015.05.001","article-title":"Nonalcoholic fatty liver disease in Latinos","volume":"14","author":"Saab S","year":"2016","unstructured":"Saab S, Manne V, Nieto J, Schwimmer JB, Chalasani NP. Nonalcoholic fatty liver disease in Latinos. Clin Gastroenterol Hepatol. 2016, 14:5-12; quiz e9-10. 10.1016\/j.cgh.2015.05.001","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/lt.26532","article-title":"Multicenter study of racial and ethnic inequities in liver transplantation evaluation: understanding mechanisms and identifying solutions","volume":"28","author":"Strauss AT","year":"2022","unstructured":"Strauss AT, Sidoti CN, Purnell TS, et al.. Multicenter study of racial and ethnic inequities in liver transplantation evaluation: understanding mechanisms and identifying solutions. Liver Transpl. 2022, 28:1841-56. 10.1002\/lt.26532","journal-title":"Liver Transpl"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2021.100304","article-title":"Waitlist mortality and transplant free survival in Hispanic patients listed for liver transplant using the UNOS database","volume":"23","author":"Goyes D","year":"2021","unstructured":"Goyes D, Danford CJ, Nsubuga JP, Bonder A. Waitlist mortality and transplant free survival in Hispanic patients listed for liver transplant using the UNOS database. Ann Hepatol. 2021, 23:100304. 10.1016\/j.aohep.2021.100304","journal-title":"Ann Hepatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2190\/986L-LHQ6-2VTE-YRRN","article-title":"The concepts and principles of equity and health","volume":"22","author":"Whitehead M","year":"1992","unstructured":"Whitehead M. The concepts and principles of equity and health. Int J Health Serv. 1992, 22:429-45. 10.2190\/986L-LHQ6-2VTE-YRRN","journal-title":"Int J Health Serv"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/131093-primary-sclerosing-cholangitis-autoimmune-hepatitis-overlap-syndrome-significant-barriers-in-liver-disease-diagnosis-and-treatment-experienced-by-the-latino-community","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:55:42Z","timestamp":1707508542000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/131093-primary-sclerosing-cholangitis-autoimmune-hepatitis-overlap-syndrome-significant-barriers-in-liver-disease-diagnosis-and-treatment-experienced-by-the-latino-community"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,14]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.36126","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,14]]}}}